These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 32912799)
21. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort. Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D; Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532 [TBL] [Abstract][Full Text] [Related]
22. Neuroendocrine-Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer's Disease and Melatonin. Spinedi E; Cardinali DP Neuroendocrinology; 2019; 108(4):354-364. PubMed ID: 30368508 [TBL] [Abstract][Full Text] [Related]
23. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease. Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499 [TBL] [Abstract][Full Text] [Related]
24. Associations of informant-based sleep reports with Alzheimer's disease pathologies. Shokouhi S Clin Interv Aging; 2019; 14():1631-1642. PubMed ID: 31571843 [TBL] [Abstract][Full Text] [Related]
25. Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease. Cedernaes J; Osorio RS; Varga AW; Kam K; Schiöth HB; Benedict C Sleep Med Rev; 2017 Feb; 31():102-111. PubMed ID: 26996255 [TBL] [Abstract][Full Text] [Related]
26. It's complicated: The relationship between sleep and Alzheimer's disease in humans. Lucey BP Neurobiol Dis; 2020 Oct; 144():105031. PubMed ID: 32738506 [TBL] [Abstract][Full Text] [Related]
27. Is Sleep Disruption a Cause or Consequence of Alzheimer's Disease? Reviewing Its Possible Role as a Biomarker. Lloret MA; Cervera-Ferri A; Nepomuceno M; Monllor P; Esteve D; Lloret A Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050587 [TBL] [Abstract][Full Text] [Related]
37. Toxic Amyloid-β42 Conformer May Accelerate the Onset of Alzheimer's Disease in the Preclinical Stage. Futamura A; Hieda S; Mori Y; Kasuga K; Sugimoto A; Kasai H; Kuroda T; Yano S; Tsuji M; Ikeuchi T; Irie K; Ono K J Alzheimers Dis; 2021; 80(2):639-646. PubMed ID: 33579852 [TBL] [Abstract][Full Text] [Related]
38. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment. Newton P; Tchounguen J; Pettigrew C; Lim C; Lin Z; Lu H; Moghekar A; Albert M; Soldan A; J Alzheimers Dis; 2023; 92(1):323-339. PubMed ID: 36744337 [TBL] [Abstract][Full Text] [Related]
39. NREM sleep as a novel protective cognitive reserve factor in the face of Alzheimer's disease pathology. Zavecz Z; Shah VD; Murillo OG; Vallat R; Mander BA; Winer JR; Jagust WJ; Walker MP BMC Med; 2023 May; 21(1):156. PubMed ID: 37138290 [TBL] [Abstract][Full Text] [Related]
40. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid. Forlenza OV; Aprahamian I; Radanovic M; Talib LL; Camargo MZ; Stella F; Machado-Vieira R; Gattaz WF Bipolar Disord; 2016 Feb; 18(1):63-70. PubMed ID: 26876913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]